| scholarly article | Q13442814 |
| P50 | author | Shu-Xiong Zeng | Q84230463 |
| P2093 | author name string | Jun Yang | |
| Fei Liu | |||
| Chuanliang Xu | |||
| Xiaowen Yu | |||
| Yinghao Sun | |||
| Zhensheng Zhang | |||
| Jinshan Xu | |||
| Qiao Xiong | |||
| Lihe Dai | |||
| Anwei Liu | |||
| Yongping Xue | |||
| P2860 | cites work | Targeting DNA topoisomerase II in cancer chemotherapy | Q24649711 |
| Molecular substratification of bladder cancer: moving towards individualized patient management | Q26744343 | ||
| Comprehensive molecular characterization of urothelial bladder carcinoma | Q28306864 | ||
| PIAS3 expression in squamous cell lung cancer is low and predicts overall survival | Q30405870 | ||
| Transcriptome sequencing identifies ANLN as a promising prognostic biomarker in bladder urothelial carcinoma. | Q33784670 | ||
| Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma | Q33807370 | ||
| Expression profiling of liposarcoma yields a multigene predictor of patient outcome and identifies genes that contribute to liposarcomagenesis. | Q34761951 | ||
| Predictive value of topoisomerase II alpha immunostaining in urothelial bladder carcinoma | Q35398592 | ||
| Top2a identifies and provides epigenetic rationale for novel combination therapeutic strategies for aggressive prostate cancer | Q35550192 | ||
| Differential expression in RNA-seq: a matter of depth | Q35581592 | ||
| The association of topoisomerase 2α expression with prognosis in surgically resected non-small cell lung cancer (NSCLC) patients | Q36186309 | ||
| The distribution and expression of the two isoforms of DNA topoisomerase II in normal and neoplastic human tissues | Q36431775 | ||
| Concurrent inhibition of enzymatic activity and NF-Y-mediated transcription of Topoisomerase-IIα by bis-DemethoxyCurcumin in cancer cells. | Q37148274 | ||
| TOP2A is overexpressed and is a therapeutic target for adrenocortical carcinoma | Q37188707 | ||
| Gene expression alterations in doxorubicin resistant MCF7 breast cancer cell line | Q39234562 | ||
| Cancer statistics in China, 2015. | Q40064386 | ||
| Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer. | Q40668752 | ||
| Untangling the role of DNA topoisomerase II in mitotic chromosome structure and function. | Q41359103 | ||
| Expression of topoisomerases II alpha and beta in Chinese hamster lung cells resistant to topoisomerase II inhibitors. | Q41449520 | ||
| Relationship between expression of topoisomerase II isoforms and intrinsic sensitivity to topoisomerase II inhibitors in breast cancer cell lines | Q42590977 | ||
| ERBB2 and TOP2A in breast cancer: a comprehensive analysis of gene amplification, RNA levels, and protein expression and their influence on prognosis and prediction. | Q43108071 | ||
| Clinical implications and prognostic values of topoisomerase-II alpha expression in primary non-muscle-invasive bladder cancer | Q44010519 | ||
| HER-2 and TOP2A coamplification in urinary bladder cancer | Q47435490 | ||
| Nuclear topoisomerase II levels correlate with the sensitivity of mammalian cells to intercalating agents and epipodophyllotoxins. | Q54373123 | ||
| Copy number variation and high expression of DNA topoisomerase II alpha predict worse prognosis of cancer: a meta-analysis. | Q55396428 | ||
| Overexpression of G2 and S phase-expressed-1 contributes to cell proliferation, migration, and invasion via regulating p53/FoxM1/CCNB1 pathway and predicts poor prognosis in bladder cancer | Q58581112 | ||
| Human DNA topoisomerase-IIalpha expression as a prognostic factor for transitional cell carcinoma of the urinary bladder | Q73172794 | ||
| Human DNA topoisomerase II-alpha: a new marker of cell proliferation in invasive breast cancer | Q73817989 | ||
| Topoisomerase IIalpha expression in breast cancer: correlation with outcome variables | Q73821356 | ||
| P433 | issue | 1 | |
| P921 | main subject | bladder urothelial carcinoma | Q18556148 |
| P304 | page(s) | 604 | |
| P577 | publication date | 2019-06-19 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | Prognostic value of TOP2A in bladder urothelial carcinoma and potential molecular mechanisms | |
| P478 | volume | 19 |
| Q92292667 | An outcome model for human bladder cancer: A comprehensive study based on weighted gene co-expression network analysis | cites work | P2860 |
Search more.